Cargando…

Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer

BACKGROUND: Pancreatic cancer (PC) remains a difficult tumor to diagnose and treat. It is often diagnosed as advanced by reason of the anatomical structure of the deep retroperitoneal layer of the pancreas, lack of typical symptoms and effective screening methods to detect this malignancy, resulting...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Shuai, Song, Lina, Tian, Ying, Zhu, Li, Guo, Kai, Zhang, Huifeng, Wang, Zhongqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579871/
https://www.ncbi.nlm.nih.gov/pubmed/34785894
http://dx.doi.org/10.2147/IJN.S335588
_version_ 1784596510510415872
author Ren, Shuai
Song, Lina
Tian, Ying
Zhu, Li
Guo, Kai
Zhang, Huifeng
Wang, Zhongqiu
author_facet Ren, Shuai
Song, Lina
Tian, Ying
Zhu, Li
Guo, Kai
Zhang, Huifeng
Wang, Zhongqiu
author_sort Ren, Shuai
collection PubMed
description BACKGROUND: Pancreatic cancer (PC) remains a difficult tumor to diagnose and treat. It is often diagnosed as advanced by reason of the anatomical structure of the deep retroperitoneal layer of the pancreas, lack of typical symptoms and effective screening methods to detect this malignancy, resulting in a low survival rate. Emodin (EMO) is an economical natural product with effective treatment and few side effects of cancer treatment. Magnetic nanoparticles (MNPs) can achieve multiplexed imaging and targeted therapy by loading a wide range of functional materials such as fluorescent dyes and therapeutic agents. PURPOSE: The purpose of this study was to design and evaluate a multifunctional theranostic nanoplatform for PC diagnosis and treatment. METHODS: In this study, we successfully developed EMO-loaded, Cy7-functionalized, PEG-coated Fe(3)O(4) (Fe(3)O(4)-PEG-Cy7-EMO). Characteristics including morphology, hydrodynamic size, zeta potentials, stability, and magnetic properties of Fe(3)O(4)-PEG-Cy7-EMO were evaluated. Fluorescence imaging (FI)/magnetic resonance imaging (MRI) and therapeutic treatment were examined in vitro and in vivo. RESULTS: Fe(3)O(4)-PEG-Cy7-EMO nanoparticles had a core size of 9.9 ± 1.2 nm, which showed long-time stability and FI/MRI properties. Bio-transmission electron microscopy (bio-TEM) results showed that Fe(3)O(4)-PEG-Cy7-EMO nanoparticles were endocytosed into BxPC-3 cells, while few were observed in hTERT-HPNE cells. Prussian blue staining also confirmed that BxPC-3 cells have a stronger phagocytic ability as compared to hTERT-HPNE cells. Additionally, Fe(3)O(4)-PEG-Cy7-EMO had a stronger inhibition effect on BxPC-3 cells than Fe(3)O(4)-PEG and EMO. The hemolysis experiment proved that Fe(3)O(4)-PEG-Cy7-EMO can be used in vivo experiments. In vivo analysis demonstrated that Fe(3)O(4)-PEG-Cy7-EMO enabled FI/MRI dual-modal imaging and targeted therapy in pancreatic tumor xenografted mice. CONCLUSION: Fe(3)O(4)-PEG-Cy7-EMO may serve as a potential theranostic nanoplatform for PC.
format Online
Article
Text
id pubmed-8579871
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85798712021-11-15 Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer Ren, Shuai Song, Lina Tian, Ying Zhu, Li Guo, Kai Zhang, Huifeng Wang, Zhongqiu Int J Nanomedicine Original Research BACKGROUND: Pancreatic cancer (PC) remains a difficult tumor to diagnose and treat. It is often diagnosed as advanced by reason of the anatomical structure of the deep retroperitoneal layer of the pancreas, lack of typical symptoms and effective screening methods to detect this malignancy, resulting in a low survival rate. Emodin (EMO) is an economical natural product with effective treatment and few side effects of cancer treatment. Magnetic nanoparticles (MNPs) can achieve multiplexed imaging and targeted therapy by loading a wide range of functional materials such as fluorescent dyes and therapeutic agents. PURPOSE: The purpose of this study was to design and evaluate a multifunctional theranostic nanoplatform for PC diagnosis and treatment. METHODS: In this study, we successfully developed EMO-loaded, Cy7-functionalized, PEG-coated Fe(3)O(4) (Fe(3)O(4)-PEG-Cy7-EMO). Characteristics including morphology, hydrodynamic size, zeta potentials, stability, and magnetic properties of Fe(3)O(4)-PEG-Cy7-EMO were evaluated. Fluorescence imaging (FI)/magnetic resonance imaging (MRI) and therapeutic treatment were examined in vitro and in vivo. RESULTS: Fe(3)O(4)-PEG-Cy7-EMO nanoparticles had a core size of 9.9 ± 1.2 nm, which showed long-time stability and FI/MRI properties. Bio-transmission electron microscopy (bio-TEM) results showed that Fe(3)O(4)-PEG-Cy7-EMO nanoparticles were endocytosed into BxPC-3 cells, while few were observed in hTERT-HPNE cells. Prussian blue staining also confirmed that BxPC-3 cells have a stronger phagocytic ability as compared to hTERT-HPNE cells. Additionally, Fe(3)O(4)-PEG-Cy7-EMO had a stronger inhibition effect on BxPC-3 cells than Fe(3)O(4)-PEG and EMO. The hemolysis experiment proved that Fe(3)O(4)-PEG-Cy7-EMO can be used in vivo experiments. In vivo analysis demonstrated that Fe(3)O(4)-PEG-Cy7-EMO enabled FI/MRI dual-modal imaging and targeted therapy in pancreatic tumor xenografted mice. CONCLUSION: Fe(3)O(4)-PEG-Cy7-EMO may serve as a potential theranostic nanoplatform for PC. Dove 2021-11-06 /pmc/articles/PMC8579871/ /pubmed/34785894 http://dx.doi.org/10.2147/IJN.S335588 Text en © 2021 Ren et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Ren, Shuai
Song, Lina
Tian, Ying
Zhu, Li
Guo, Kai
Zhang, Huifeng
Wang, Zhongqiu
Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer
title Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer
title_full Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer
title_fullStr Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer
title_full_unstemmed Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer
title_short Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer
title_sort emodin-conjugated pegylation of fe(3)o(4) nanoparticles for fi/mri dual-modal imaging and therapy in pancreatic cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579871/
https://www.ncbi.nlm.nih.gov/pubmed/34785894
http://dx.doi.org/10.2147/IJN.S335588
work_keys_str_mv AT renshuai emodinconjugatedpegylationoffe3o4nanoparticlesforfimridualmodalimagingandtherapyinpancreaticcancer
AT songlina emodinconjugatedpegylationoffe3o4nanoparticlesforfimridualmodalimagingandtherapyinpancreaticcancer
AT tianying emodinconjugatedpegylationoffe3o4nanoparticlesforfimridualmodalimagingandtherapyinpancreaticcancer
AT zhuli emodinconjugatedpegylationoffe3o4nanoparticlesforfimridualmodalimagingandtherapyinpancreaticcancer
AT guokai emodinconjugatedpegylationoffe3o4nanoparticlesforfimridualmodalimagingandtherapyinpancreaticcancer
AT zhanghuifeng emodinconjugatedpegylationoffe3o4nanoparticlesforfimridualmodalimagingandtherapyinpancreaticcancer
AT wangzhongqiu emodinconjugatedpegylationoffe3o4nanoparticlesforfimridualmodalimagingandtherapyinpancreaticcancer